14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries.
about
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesImpact of soluble epoxide hydrolase and epoxyeicosanoids on human healthEpoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular functionCYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Targeting epoxides for organ damage in hypertensionEpoxides and soluble epoxide hydrolase in cardiovascular physiologyRole of soluble epoxide hydrolase in postischemic recovery of heart contractile functionEpoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injuryDevelopment of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actionsThematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscleVascular pharmacology of epoxyeicosatrienoic acidsEmerging role of epoxyeicosatrienoic acids in coronary vascular function.Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.Epoxyeicosatrienoic acid analogs and vascular function.14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a Uighur population.Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase.Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid.Orally Active Epoxyeicosatrienoic Acid Analogs.Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population.
P2860
Q24597172-392D1572-117D-410C-91CC-0E3933B02A04Q24618018-0A08F8C2-4D9E-4303-B25B-54FB38E2A155Q26849271-81FF9525-C117-455D-9B0C-2C20FD150848Q28307304-396502BE-A7F8-4037-B630-0EC3286981B6Q28387558-46A7BB5B-F516-4CEB-BCB2-CFDEF8E2D758Q28396313-5E17BFA2-B28D-4165-B6CB-E5085D9F46B3Q28397090-24EACDBB-1491-4F0B-A47B-B8023C2CB4AEQ33904690-66842F1E-19C7-455D-8CB2-224EEFB1481FQ34205948-FF644A59-8280-4409-9689-BE5D53C8DFF5Q34229608-3AFABEA7-B442-4F8F-A652-94A6A1CEACD5Q34588685-18FE9A21-34F4-4FB9-B759-78B1EE9B1694Q34691742-0D182EB5-C25B-424B-94CF-632D33BF9E4CQ34952213-35FDACB0-9CFC-4E53-A087-690A3AA8AC21Q34999553-009F5B1E-FE2B-441C-B71E-5866C5A5D3C7Q35900959-BEC8EC50-02CB-4F78-B911-9468F92385F9Q35954870-372A045D-7D9D-478C-BA0E-07632143E6F2Q36027183-818224C7-616E-4636-8C8C-1015DCD0ECFAQ36458500-15A6BC1C-29AB-4464-AEBB-958016945A0BQ36938417-0E41611F-5C9E-46A1-AFEF-AF825BBD914DQ37125720-99514787-E684-4A78-A232-5DD9AEB42DB6Q37405408-B6AE16F5-91E1-472A-9759-970AB556E652Q37693177-CAD2DB5F-8C7D-4CC8-96E1-2387132FECF4Q41202514-A99C5090-334B-48CE-838B-6FFEEC8AE356Q42070301-CAF7BACA-82DF-4B8B-BB69-E96DF9CD6C84Q42163588-E2CD4757-BF1B-4AB1-BB02-D72F09DD9DE3Q46688375-E68F52E0-F8C9-47AF-BFFC-322F7E4B60F2Q46990614-BA750F45-B656-43DB-973E-D506A62D6A55Q49929536-DC9BF49D-C816-4CD1-9CA1-815FD1B6B0BDQ54387056-17818E76-7FE7-450D-A60B-D4FE55C1B014
P2860
14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
14,15-EET analogs: characteriz ...... y in bovine coronary arteries.
@ast
14,15-EET analogs: characteriz ...... y in bovine coronary arteries.
@en
type
label
14,15-EET analogs: characteriz ...... y in bovine coronary arteries.
@ast
14,15-EET analogs: characteriz ...... y in bovine coronary arteries.
@en
prefLabel
14,15-EET analogs: characteriz ...... y in bovine coronary arteries.
@ast
14,15-EET analogs: characteriz ...... y in bovine coronary arteries.
@en
P2093
P1476
14,15-EET analogs: characteriz ...... ty in bovine coronary arteries
@en
P2093
Kathryn M Gauthier
L Manmohan Reddy
William B Campbell
P304
P356
10.1016/J.PHRS.2003.09.014
P577
2004-06-01T00:00:00Z